Menu

#BioTech

24 posts

Feed·
20 of 24 posts
Moderna CEO on what’s next after success in cancer vaccine
📰
0Read More

Moderna CEO on what’s next after success in cancer vaccine

Business - Latest - Google News·about 9 hours ago
#qoVQjunt
#world#news#statnews#stat#biotech

Moderna's CEO Stéphane Bancel on what's next after the recent success of a cancer vaccine, and how that impacts the company's business strategy.

15s
Biotech stocks are surging. How investors can play the new drug innovation boom
📰
0Read More

Biotech stocks are surging. How investors can play the new drug innovation boom

US Top News and Analysis·1 day ago
#CbEC2FXK
#cnbc#business#drug#biotech#companies

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

15s
Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
🖼️
0Read More

Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

Business - Latest - Google News·3 days ago
#BHg05Ib5
#world#news#statnews#biotech#adam

An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.

15s
U.S. IPO Weekly Recap: Trickle Of Biotech Activity Continues Amid Tech Sell-Off
🖼️
0Read More

U.S. IPO Weekly Recap: Trickle Of Biotech Activity Continues Amid Tech Sell-Off

All Articles on Seeking Alpha·3 days ago
#XuvlBkto
#seekingalpha#biotech#week#filings#debuted

One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. Read more here.

15s
Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
📰
0Read More

Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial

Business - Latest - Google News·4 days ago
#c8t0V1Kf
#world#news#statnews#biotech#stat

A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to standard treatment.

15s
Krystal Biotech, Inc. (KRYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
🖼️
0Read More

Krystal Biotech, Inc. (KRYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha·SA Transcripts·6 months ago
#u0k2tz9S
#source#chevron#alpha#alec#president

Krystal Biotech, Inc. (KRYS) Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsKrish Krishnan - Founder,...

15s
FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
📰
0Read More

FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)

Seeking Alpha·Edmund Ingham·6 months ago
#ht6GHrKO
#source#chevron#alpha#investment#seeking

FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look at the issues surrounding the FDA.

15s
Can You Steer It? Introducing SEWO — A Steerable Medicine World Model Framework
🖼️
0Read More

Can You Steer It? Introducing SEWO — A Steerable Medicine World Model Framework

DEV Community·JXIONG·6 months ago
#WqtwpvAn
#machinelearning#ai#biotech#model#world

From Dev RSS Feed: Can You Steer It? Introducing SEWO — A Steerable Medicine World Model Framework

15s
Watch Bernstein's Liang on China's Edge in Pharma Sector - Bloomberg
📰
0Read More

Watch Bernstein's Liang on China's Edge in Pharma Sector - Bloomberg

Bloomberg·@HashtagPLUS·6 months ago
#PgDCPn3V
#that#liang#china#biotech#27th

China has been closing the gap with the US in biotech and pharmaceutical research, with the proportion of studies being conducted by Chinese scientists increasing.…

15s
'A Race to the Starting Line': Diagnosing What's Holding Biotechnology Back
📰
0Read More

'A Race to the Starting Line': Diagnosing What's Holding Biotechnology Back

Knowledge at Wharton·@HashtagPLUS·6 months ago
#Dc8vmaKv

New strategies will be necessary for biotechnology companies to thrive in the new era of personalized medicine, but the healthcare system itself will also have to change, according to a panel of biotechnology company representatives at the 2008 Wharton…

15s